HIV11: Stribild Matches Efficacy and ...

HIV11: Stribild Matches Efficacy and Tolerability of Atripla or Boosted Atazanavir at 96 Weeks

There are 1 comment on the HIV and Hepatitis story from Nov 27, 2012, titled HIV11: Stribild Matches Efficacy and Tolerability of Atripla or Boosted Atazanavir at 96 Weeks. In it, HIV and Hepatitis reports that:

The Stribild single-tablet-regimen -- formerly dubbed the Quad -- demonstrated "robust and durable" efficacy and continued to be well-tolerated through 96 weeks, according to findings from 2 studies presented at the 11th International Congress on Drug Therapy in HIV Infection this month in Glasgow.

Join the discussion below, or Read more at HIV and Hepatitis.

kmc2749

Austin, TX

#1 Jan 15, 2013
Learn more about the HIV/AIDS drug Atripla at http://www.rxwiki.com/atripla

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Gilead Sciences Discussions

Title Updated Last By Comments
News Fight over $1,100 hepatitis C pills awaits next... (Dec '14) Dec '14 reneir880 1
News Gilead Sciences Under Investigation for Over-Ch... (Jul '14) Jul '14 Chris 1
News FDA Panel OKs Truvada for HIV Prevention (May '12) May '14 Sheldon 6
News $1,000 hepatitis C pill a tough miracle to swallow (May '14) May '14 Hep C Veterans 1
News Divide over HIV prevention drug Truvada persists (Apr '14) Apr '14 juls 2
News FDA advisors back new Hepatitis C drug (Oct '13) Oct '13 WARNING FDA APPROVED 1
News Gilead's Sofosbuvir for Hepatitis C Meets Prima... (Feb '13) Feb '13 Axel 1
More from around the web